Yinmeng Yang

1.6k total citations
18 papers, 877 citations indexed

About

Yinmeng Yang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yinmeng Yang has authored 18 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Yinmeng Yang's work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Yinmeng Yang is often cited by papers focused on CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Yinmeng Yang collaborates with scholars based in United States and Canada. Yinmeng Yang's co-authors include Terry J. Fry, Elad Jacoby, Haiying Qin, Christopher D. Chien, Jonathan D. Ashwell, Melanie S. Vacchio, M. Eric Kohler, Delisha A. Stewart, Liza Makowski and Melissa A. Troester and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Yinmeng Yang

18 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinmeng Yang United States 9 662 338 325 210 174 18 877
Sanfang Tu China 16 582 0.9× 297 0.9× 201 0.6× 154 0.7× 144 0.8× 52 858
Brandon Ballard United States 10 847 1.3× 326 1.0× 311 1.0× 259 1.2× 226 1.3× 16 1.0k
Kevin G. Pinz United States 19 862 1.3× 741 2.2× 470 1.4× 341 1.6× 122 0.7× 24 1.4k
Sang M. Nguyen United States 10 1.2k 1.9× 418 1.2× 370 1.1× 376 1.8× 437 2.5× 16 1.4k
Semjon Willier Germany 11 422 0.6× 343 1.0× 175 0.5× 131 0.6× 94 0.5× 21 707
Greta Maria Paola Giordano Attianese Switzerland 14 565 0.9× 219 0.6× 363 1.1× 221 1.1× 85 0.5× 21 759
Caroline Arber United States 16 504 0.8× 235 0.7× 343 1.1× 164 0.8× 132 0.8× 30 762
Scott E. James United States 9 1.0k 1.6× 374 1.1× 482 1.5× 392 1.9× 304 1.7× 12 1.2k
Julian Rydzek Germany 5 741 1.1× 300 0.9× 287 0.9× 205 1.0× 265 1.5× 7 850
Anton Dobrin United States 8 885 1.3× 360 1.1× 393 1.2× 234 1.1× 346 2.0× 12 1.0k

Countries citing papers authored by Yinmeng Yang

Since Specialization
Citations

This map shows the geographic impact of Yinmeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinmeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinmeng Yang more than expected).

Fields of papers citing papers by Yinmeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinmeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinmeng Yang. The network helps show where Yinmeng Yang may publish in the future.

Co-authorship network of co-authors of Yinmeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yinmeng Yang. A scholar is included among the top collaborators of Yinmeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinmeng Yang. Yinmeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yang, Yinmeng, Ryan Murray, Faith Musenge, et al.. (2021). 155 CD5 knockout enhances the potency of multiplex base-edited allogeneic anti-CD5 CAR T-cell therapy for the treatment of T-cell malignancies. Regular and Young Investigator Award Abstracts. A165–A165. 2 indexed citations
2.
Yang, Yinmeng, et al.. (2019). Immunobiology of chimeric antigen receptor T cells and novel designs. Immunological Reviews. 290(1). 100–113. 17 indexed citations
3.
Yang, Yinmeng, M. Eric Kohler, & Terry J. Fry. (2017). Effect of Chronic Endogenous Antigen Stimulation on CAR T Cell Persistence and Memory Formation. Blood. 130. 166–166. 5 indexed citations
5.
Yang, Yinmeng, M. Eric Kohler, Christopher D. Chien, et al.. (2017). TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance. Science Translational Medicine. 9(417). 152 indexed citations
6.
Jacoby, Elad, Sang M. Nguyen, Thomas J. Fountaine, et al.. (2016). CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nature Communications. 7(1). 12320–12320. 293 indexed citations
7.
Yang, Yinmeng, M. Eric Kohler, & Terry J. Fry. (2016). Modeling Retreatment of Acute Lymphoblastic Leukemia with Anti-CD19 Chimeric Antigen Receptor T Cell Therapy. Blood. 128(22). 2806–2806. 2 indexed citations
8.
Yang, Yinmeng, Elad Jacoby, & Terry J. Fry. (2015). Challenges and opportunities of allogeneic donor-derived CAR T cells. Current Opinion in Hematology. 22(6). 509–515. 79 indexed citations
10.
Jacoby, Elad, Yinmeng Yang, Haiying Qin, et al.. (2015). Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD. Blood. 127(10). 1361–1370. 77 indexed citations
11.
Jacoby, Elad, Sang M. Nguyen, Haiying Qin, et al.. (2015). Lineage Switch As a Relapse Mechanism of Pre-B Acute Lymphoblastic Leukemia Following CD19 CAR. Blood. 126(23). 2524–2524. 5 indexed citations
12.
Jacoby, Elad, et al.. (2015). Abstract 4705: Late ALL relapse following CD19 CAR immune-pressure demonstrates reversible pan-antigen loss. Cancer Research. 75(15_Supplement). 4705–4705. 1 indexed citations
13.
Stewart, Delisha A., Yinmeng Yang, Liza Makowski, & Melissa A. Troester. (2012). Basal-like Breast Cancer Cells Induce Phenotypic and Genomic Changes in Macrophages. Molecular Cancer Research. 10(6). 727–738. 84 indexed citations
14.
Yang, Yinmeng, Saverio Minucci, Dina J. Zand, Keiko Ozato, & Jonathan D. Ashwell. (1994). T cell activation and increases in protein kinase C activity enhance retinoic acid-induced gene transcription.. Molecular Endocrinology. 8(10). 1370–1376. 9 indexed citations
15.
Cole, David J., Jeffrey K. Taubenberger, Barbara A. Pockaj, et al.. (1994). Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes. Cancer Immunology Immunotherapy. 38(5). 299–303. 25 indexed citations
16.
Cole, David J., Jeffrey K. Taubenberger, Barbara A. Pockaj, et al.. (1994). Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes. Cancer Immunology Immunotherapy. 38(5). 299–303. 2 indexed citations
18.
Yang, Yinmeng, Melanie S. Vacchio, & Jonathan D. Ashwell. (1993). 9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development.. Proceedings of the National Academy of Sciences. 90(13). 6170–6174. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026